Letters to the Editor
Vol. 3 No. 1 (2024)
ReDIP, the Italian network for the diagnosis of congenital platelet function disorders
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 22 April 2024
468
Views
149
Downloads
Authors
Congenital platelet function disorders (cPFD) are associated with an increased risk of mucocutaneous bleeding of various levels of severity; they may be classified based on abnormalities of platelet components that share common characteristics: i) platelet receptors for adhesive proteins; ii) platelet receptors for soluble agonists; iii) platelet granules; iv) signal transduction pathways; v) procoagulant phospholipids; less well characterized PFD aregrouped in a sixth category of miscellaneous abnormalities [...].
Downloads
Download data is not yet available.
Citations
Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003;:1628-36 DOI: https://doi.org/10.1046/j.1538-7836.2003.00266.x
Quiroga T, Goycoolea M, Panes O, et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007;92:357-65 DOI: https://doi.org/10.3324/haematol.10816
Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-9 DOI: https://doi.org/10.1182/blood.V69.2.454.454
Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010;8:2063-5 DOI: https://doi.org/10.1111/j.1538-7836.2010.03975.x
Lowe GC, Lordkipanidzé M, Watson SP et al. Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. J Thromb Haemost 2013;11:1663-8 DOI: https://doi.org/10.1111/jth.12332
Podda GM, Bucciarelli P, Lussana F et al. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time. J Thromb Haemost. 2007;5:2393-8 DOI: https://doi.org/10.1111/j.1538-7836.2007.02752.x
Cattaneo M. Congenital disorders of platelet function. In: AD Michelson, ed. Platelets, 3rd editon. San Diego, CA: Elsevier/Academic Press; 2013. pp 1019-47 DOI: https://doi.org/10.1016/B978-0-12-387837-3.00050-X
How to Cite
1.
Cattaneo M, Ghali C, Scavone M. ReDIP, the Italian network for the diagnosis of congenital platelet function disorders. Bleeding Thromb Vascul Biol [Internet]. 2024 Apr. 22 [cited 2025 Nov. 10];3(1). Available from: https://www.btvb.org/btvb/article/view/134
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Share
Similar Articles
- CO39 | Artificial intelligence in hemophilia management: challenging the need for experts , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO05 | Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO44 | Emicizumab in acquired haemophilia A , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares, Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024)
- Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo, Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition? , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- PO20 | Impact of endovascular treatment on functional outcome in ischemic stroke: a real-world retrospective study , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO23 | Markers of inflammation and hypofibrinolysis are associated with cognitive dysfunction and motor performances in atrial fibrillation patients on oral anticoagulant therapy: insights from the Strat-AF study , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CS02 | Functional and structural impairments of the cerebral microcirculation in a mouse model of hemophilia A , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Giovanni de Gaetano, Artificial intelligence, platelets and aspirin , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 1 (2024)
- CS01 | Elucidating the evil relationship of metabolic dysfunction–associated fatty liver disease with cardiovascular comorbidities: the complex interplay among hypercoagulability, inflammation and liver fibrosis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Bianca Clerici, Mariangela Scavone, Gian Marco Podda, Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
- Marco Cattaneo, Guided antiplatelet therapy in patients undergoing percutaneous coronary intervention , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
